A Novel Tumor-Targeted Therapy Using a Claudin-4-Targeting Molecule
Authors:
- Masuo KondohMKMasuo Kondoh
- Hideki KakutaniHKHideki Kakutani
- Shin-Ichi TsunodaSTShin-Ichi Tsunoda
- Yasuhiro MochizukiYMYasuhiro Mochizuki
- Takao HamakuboTHTakao Hamakubo
- Yasuo TsutsumiYTYasuo Tsutsumi
- Yasuhiko HoriguchiYHYasuhiko Horiguchi
- Kiyohito YagiKYKiyohito Yagi
- 1 October 2009
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 76 (4) , 918-926
Abstract
Carcinogenesis is often accompanied by dysfunctional tight junction (TJs), resulting in the loss of cellular polarity. Claudin, a tetra-transmembrane protein, plays a pivotal role in the barrier and fence functions of TJs. Claudin-4 is deregulated in various cancers, including breast, prostate, ovarian, and gastric cancer. Claudin-4 may be a promising target molecule for tumor therapy, but the claudin-targeting strategy has never been fully developed. In the present study, we prepared a claudin-4-targeting molecule by fusion of the C-terminal fragment of Clostridium perfringens enterotoxin (C-CPE) with the protein synthesis inhibitory factor (PSIF) derived from Pseudomonas aeruginosa exotoxin. PSIF was not cytotoxic to claudin-4-expressing cells, whereas C-CPE-PSIF was cytotoxic. Cells that express claudin-1, -2, and -5 were less sensitive to C-CPE-PSIF. Pretreatment of the cells with C-CPE attenuated C-CPE-PSIF-induced cytotoxicity, and mutation of C-CPE in the claudin-4-binding residues attenuated the cytotoxicity of C-CPE-PSIF. TJ-undeveloped cells were more sensitive to C-CPE-PSIF than TJ-developed cells. It is noteworthy that polarized epithelial cells are sensitive to C-CPE-PSIF applied to the basal side, whereas the cells were less sensitive to C-CPE-PSIF applied to the apical side. Intratumoral injection of C-CPE-PSIF reduced tumor growth. This is the first report to indicate that a claudin-4-targeting strategy may be a promising method to overcome the malignant tumors.Keywords
This publication has 35 references indexed in Scilit:
- A Simple Detection Method for Low-Affinity Membrane Protein Interactions by Baculoviral DisplayPLOS ONE, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Preparation of a Claudin-Targeting Molecule Using a C-Terminal Fragment of Clostridium perfringens EnterotoxinThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Claudin Proteins in Human Cancer: Promising New Targets for Diagnosis and TherapyCancer Research, 2005
- Treatment of Chemotherapy-Resistant Human Ovarian Cancer Xenografts in C.B-17/SCID Mice by Intraperitoneal Administration of Clostridium perfringens EnterotoxinCancer Research, 2005
- Drug Delivery Systems: Entering the MainstreamScience, 2004
- Claudin 4 Protein Expression in Primary and Metastatic Pancreatic CancerAmerican Journal of Clinical Pathology, 2004
- Segregation of receptor and ligand regulates activation of epithelial growth factor receptorNature, 2003
- Genes for the CPE Receptor (CPETR1) and the Human Homolog of RVP1 (CPETR2) Are Localized within the Williams–Beuren Syndrome DeletionGenomics, 1998
- Delivery of Novel Therapeutic Agents in Tumors: Physiological Barriers and StrategiesJNCI: Journal of the National Cancer Institute, 1989